Unicycive Therapeutics, Inc. (UNCY) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 916.67M |
| Enterprise Value | 887.67M |
| P/E Ratio | -3.84 |
| PEG Ratio | 0.13 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 49.9 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.38 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.62 |
| Return On Equity | -1.31 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -572,000 |
| EBITDA | -25.91M |
| Net Income | -26.56M |
| Diluted EPS | -1.67 |
| Total Cash | 54.59M |
| Total Cash/Share | 0.23 |
| Total Debt | 941,000 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 2.4 |
| Book Value Per Share | 0.16 |
| 52-Week Change | 10.69 |
| 52-Week High | 8.74 |
| 52-Week Low | 3.71 |
| Moving Average 50 Days | 7.44 |
| Moving Average 200 Days | 6.15 |
| Average Volume | 681,120 |
| Shares Outstanding | 21.49M |
| % Held by Institutions | 6.24 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | June 20, 2025 |